Kangfuxin Ye — 2326757
Application number
2326757
Registration number
TMA1361678
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2024-05-13
Registered
2025-11-21
Registration Expiry Date
2035-11-21
Registered Owner
Sichuan Good Doctor Panxi Pharmaceutical Co., Ltd.
NO. 115, 3rd Section of Airport Road
Xichang City
Liangshan Yi Autonomous Prefecture, Sichuan, 615000
CHINA
Agent
SMART & BIGGAR LP
SCOTIA PLAZA
40 KING STREET WEST
40th FLOOR
TORONTO
ONTARIO M5H3Y2
Address for Service
Bereskin & Parr LLP/S.E.N.C.R.L., S.R.L.
Scotia Plaza
40 King Street West, 40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Index headings
- KANGFUXIN YE
Goods (Nice class & Statement)
- 5
- (1) Analgesics; antibacterial wound dressings; chinese traditional medicinal herbs for the treatment of colds and flu; dietary and nutritional supplements for general health and wellbeing; dietetic food and substances adapted for medical and veterinary use for general health and well-being; dietetic food and substances adapted for medical use for the prevention and treatment of gastrointestinal diseases and disorders; disinfectants for household purposes; gastrointestinal treatment preparations; human pharmaceutical preparations for the relief of pain; medicated skin preparations for the treatment of sores; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of scleroderma digital ulcers; pharmaceutical preparations for the treatment of digestive diseases and disorders, namely, ulcerative colitis; pharmaceutical preparations for the treatment of sports injuries, namely, injured and torn skin, muscle, ligaments, and bone; preparations for the treatment of burns
- 5
- (2) Pharmaceutical preparations for bleeding arresting; pharmaceutical preparations for the treatment of trauma and swelling; pharmaceutical preparations for use in activating blood circulation and elimination of blood stasis, to relieve muscular contracture, to remove swelling and pain, to treat traumatic injuries, and to eliminate fatigue before and after exercise.
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2024-05-13 | ||
| Created | 2024-05-13 | ||
| Formalized | 2024-05-13 | ||
| Pre-Assessment Letter Sent | 2024-05-23 | Goods or Services Not Acceptable | |
| Agent Name Changed | 2024-09-27 | ||
| Agent Name Changed | 2024-09-27 | ||
| Search Recorded | 2025-07-29 | ||
| Approved | 2025-08-07 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2025-08-07 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2025-09-03 | Vol.72 Issue 3697 | |
| Registration Pending | 2025-11-21 | ||
| Registered | 2025-11-21 | 2035-11-21 |